Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Morgan Rouprêt, ESOU22: Impact of Immune Checkpoint Inhibitors on the Treatment of Bladder, Prostate and Kidney Cancer

5 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 18th 2022

touchONCOLOGY are joined by the EAU Section of Oncological Urology (ESOU) Chairman Professor Morgan Rouprêt to discuss the impact of immune checkpoint inhibitors on the treatment of bladder cancer, and other exciting therapeutic advances.

Questions

  1.       How have immune checkpoint inhibitors changed the treatment landscape for bladder cancer? (00:35-03:35)
  2.       What are the most exciting recent and emerging therapeutic advances in bladder cancer? (03:35-05:05)

Speaker Disclosure: Morgan Rouprêt has no conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the EAU Section of Oncological Urology (ESOU) 2022 conference.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup